Real-world data on usage of the tyrosine kinase inhibitor nintedanib (Ofev; Boehringer Ingelheim) suggest there is ...
The study shows a significant drop in CRS and ICANS risk 15 days after liso-cel infusion, supporting reduced monitoring ...
KYV-101 demonstrated significant efficacy in reducing MG-ADL and QMG scores in gMG patients, with rapid and sustained effects ...
The global burden of chronic lymphocytic leukemia (CLL) has decreased over the past 30 years, according to a new analysis. However, the authors of the new report published in Cancer Control noted that ...
Elevated CTI values correlate with higher odds of RA, even after adjusting for demographic, socioeconomic, lifestyle, and clinical factors. Elevated levels of a combined biomarker integrating CRP, ...
Ryan Haumschild, PharmD, discusses overcoming barriers to cancer care access, emphasizing the role of pharmacy in improving access and affordability. Novel therapies have revolutionized the cancer ...
NPM1 minimal residual disease (MRD) positivity before allogeneic hematopoietic cell transplantation is linked to higher relapse rates and lower overall survival in patients with acute myeloid leukemia ...
Ultimately, investigators found a significant reduction in ischemic stroke risk with asundexian compared to placebo, both in combination with antiplatelet therapy. Additionally, participants had no ...
Nearly 60% of patients with high-grade serous ovarian cancer (HGSOC) had a qualifying index surgery during which an opportunistic salpingectomy could have been performed, often an average of 3 decades ...
Acoramidis significantly reduced all-cause mortality in both wild-type and variant amyloid cardiomyopathy through 42 months of the ATTRibute-CM study. The study demonstrated consistent efficacy in ...
The uninsured rates may skyrocket when Medicaid work requirements go into effect and if the Affordable Care Act (ACA) ...
A retrospective analysis of anti–B-cell maturation antigen (BCMA) chimeric antigen receptor T-cell (CAR T) therapy outcomes ...